Back |
home / stock / myov / myov message board
Subject | By | Source | When |
---|---|---|---|
Go baby go!! $MYOV! Going up on | Cosa | investorshub | 06/07/2022 6:35:27 PM |
The deal terms were not better than expected, | DewDiligence | investorshub | 05/10/2022 2:25:22 AM |
Good news does nothing in fearful market. | Cosa | investorshub | 05/09/2022 11:28:40 PM |
I'm holding bags for sure lol | Cosa | investorshub | 05/09/2022 7:26:31 PM |
$MYOV bags European partner for Orgovyx: | DewDiligence | investorshub | 05/09/2022 3:43:13 PM |
Cheers Bro! buying the dip in both | Cosa | investorshub | 04/29/2022 12:57:49 AM |
Cosa, I see you are also into$ MYOV. I | winepro1 | investorshub | 04/28/2022 3:13:42 PM |
I think you're taking the smarter approach. | Cosa | investorshub | 04/22/2022 7:01:28 PM |
Hoping I dont miss the boat but | randychub | investorshub | 04/21/2022 6:19:11 PM |
Market cap below $1B. 2 year low. | Cosa | investorshub | 04/21/2022 6:09:24 PM |
There is still time for the FDA to | DewDiligence | investorshub | 04/13/2022 1:57:28 PM |
The FDA noted that the letter does not | randychub | investorshub | 04/13/2022 1:51:56 PM |
AviseAnalytics: 4 STOCKS OPENING NEW FRONTIERS IN WOMENS HEALTH! $MYGN $SERA $PGNY $MYOV 8th Marc | AviseAnalytics | investorshangout | 03/08/2022 3:50:32 PM |
News, Short Squeeze, Breakout and More Instantly...
Myovant Sciences Ltd. Company Name:
MYOV Stock Symbol:
NYSE Market:
NEW YORK, NY / ACCESSWIRE / October 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myovant Sciences, Ltd. ("Myovant" or "the Company") (NYSE:MYOV). Investors who purchased Myovant securities are encouraged to obtain additional infor...
Third fiscal quarter 2022 total revenue of $100.2 million ; including net product revenue of $61.4 million Net product revenue from U.S. sales of ORGOVYX ® of $48.7 million in third fiscal quarter 2022, with sequential quarterly demand volume ...
MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant Sciences MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant Sciences PR Newswire ...